Logo
Gioluxe Eyes

Gioluxe Eyes

Gioluxe

Injectable polynucleotide-based eye area treatment
  • CE Marked medical device for aesthetic use within the European Community (EC)
  • Distributed by licensed medical and aesthetic device wholesalers for professional use only
  • Intended to be used in compliance with applicable EU/EEA medical device and local regulatory requirements
Under-eye / periorbital polynucleotide injectable (mesotherapy / skin booster)

Description

Gioluxe Eyes is a CE-marked, polynucleotide (PDRN) based injectable designed specifically for the delicate under-eye and periorbital area. Formulated with marine-sourced polynucleotides derived from purified trout DNA and supporting actives such as hyaluronic acid, glutathione, niacinamide, vitamins and peptides, it promotes deep tissue regeneration, hydration and biostimulation. The treatment targets dark circles, fine lines, signs of fatigue and uneven skin tone, improving skin density, firmness and overall quality with minimal downtime.

Bnefits

  • Regenerates skin at the cellular level via polynucleotides (PDRN)
  • Brightens dark circles and helps even out under-eye skin tone
  • Reduces signs of fatigue, puffiness and fine lines around the eyes
  • Improves hydration, elasticity and overall skin quality in the periorbital area
  • Stimulates collagen, elastin and extracellular matrix for firmer, denser skin
  • Acts as a tissue booster that can help refine pores, soften acne scars and support wound recovery
  • Provides fast-absorbing, natural-looking results with minimal downtime
  • Allows immediate or same-day return to normal daily activities

Indications

  • Dark circles and pigmentation irregularities in the under-eye area
  • Fine lines, crepiness and early signs of ageing around the eyes
  • Dull, dehydrated or thin under-eye skin
  • Tired-looking eyes and signs of fatigue in the periorbital region
  • Uneven skin tone and texture around the eyes
  • Adjunct treatment to improve skin quality where pores, mild acne scarring or superficial dermal damage are present

Composition

  • Polynucleotides (PDRN) – marine sourced, derived from purified trout DNA (2 mg polynucleotides per 1 ml syringe)
  • Hyaluronic Acid – low and high molecular weight
  • Glutathione (GSH)
  • Vitamin B3 (Niacinamide)
  • Vitamin B12
  • SA (Succinic Acid)
  • AH8 (Acetyl Hexapeptide-8)
  • Amino Acids (AAs)
  • ECM Moduline and other extracellular matrix supporting components

Formulation

  • Sterile, injectable gel-like solution for professional use only
  • Polynucleotide-based biostimulatory complex targeting the under-eye and periorbital region
  • Low molecular weight PDRN complex to support tissue regeneration and cellular repair
  • Multifunctional blend combining biostimulation, antioxidant protection, brightening and hydration

Packaging

  • 1 prefilled sterile syringe x 1 ml per pack
  • Each syringe contains approximately 2 mg marine-sourced polynucleotides (PDRN) in 1 ml
  • Supplied as a CE-marked medical device intended for professional use
  • Some distributor lots may be supplied as short-dated stock (e.g., expiry 20/12/2025 as noted for specific Teleta batches)

Usage

  • For professional use only; to be injected by trained and qualified medical or aesthetic practitioners in an appropriate clinical setting.
  • Indicated for intradermal/injection treatment of the under-eye and periorbital area (including crow’s feet) following the technique and depth recommended in the official instructions for use.
  • Typical protocol: visible results may be seen after a single treatment; a course of approximately 3 treatment sessions is commonly recommended with around 4-week intervals between sessions.
  • Maintenance: repeat treatment courses approximately twice per year (or as clinically indicated) to maintain and enhance results.
  • After treatment, patients can usually resume normal daily activities; transient redness, small papules or mild swelling at injection sites typically resolve within hours to a few days.
  • Always review the full product leaflet/IFU and comply with local regulations and best clinical practice before administration.

Contraindications

  • Do not use in patients with known hypersensitivity or allergy to fish/seafood or any component of the formulation.
  • Do not inject into areas with active skin infections, inflammation or open wounds.
  • Use is generally not recommended in pregnant or breastfeeding patients unless clearly justified and permitted by local regulations.
  • Contraindicated in patients with known severe systemic illnesses or conditions where injectable aesthetic procedures are inadvisable, unless assessed and cleared by a physician.
  • Always consult the manufacturer’s instructions for use and follow local regulatory and professional guidelines for full contraindication details.

Adverse Effects

  • Transient redness and small papules at the injection site immediately after treatment, typically resolving within hours.
  • Mild swelling, tenderness or bruising in the treated area.
  • Temporary discomfort or stinging sensation during injection.
  • As with any injectable procedure, rare risks include infection, inflammatory reactions, hypersensitivity reactions and vascular compromise; practitioners should be trained to recognise and manage complications.
  • Any unexpected, persistent or severe adverse events should be evaluated by a qualified healthcare professional.

Storage Conditions

  • Store in accordance with the manufacturer’s instructions for use on the pack/labelling.
  • Typically kept at controlled room temperature away from extreme heat and direct sunlight.
  • Do not freeze the product and protect the sterile packaging from damage.
  • Keep out of reach of unauthorised persons and use only before the labelled expiry date.

Duration

Course of ~3 sessions spaced about 4 weeks apart, with maintenance courses recommended roughly twice yearly; improvements can last several months depending on individual skin condition and protocol.

Onset

Many patients notice initial brightening and plumping of the under-eye area after the first session; full regenerative benefits develop progressively over the complete treatment course.

Browse more Injectable polynucleotide-based eye area treatment

Top Treatments

Top Cities in the UK